Ballantyne Garth H, Wasielewski Annette, Saunders John K
Section of Minimally Invasive Surgery, Hackensack University Medical Center, 20 Prospect Avenue, Suite #901, Hackensack, NJ 07601, USA.
Obes Surg. 2009 Sep;19(9):1297-303. doi: 10.1007/s11695-009-9870-2. Epub 2009 Jul 23.
Bariatric operations significantly improve glucose metabolism, decrease insulin resistance, and lead to clinical resolution of type II diabetes mellitus in many patients. The mechanisms that achieve these clinical outcomes, however, remain ill defined. Moreover, the relative impact of various operations on insulin resistance remains vigorously contested. Consequently, the purpose of this study was to compare directly the impact of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB) on hemoglobin A1c (HbA1c) levels and insulin resistance in comparable groups of morbidly obese patients.
Data were entered prospectively into our bariatric surgery database and reviewed retrospectively. Patients selected operations. Principle outcome variables were percent excess weight loss (%EWL), HbA1c, and homeostatic model assessment for insulin resistance (HOMA IR).
The number of follow-up visits for 111 LAGB patients was 263 with a median of 162 days (17-1,016) and 291 follow-up visits for 104 LRYGB patients for a median of 150 days (8-1,191). Preoperative height, weight, body mass index, age, sex, race, comorbidities, fasting glucose, insulin, HbA1c, and HOMA IR were similar for both groups. In particular, the number of patients who were diabetics and those receiving insulin and other hypoglycemic agents were similar among the two groups. The LAGB patients lost significantly less weight than the LRYGB patients (24.6% compared to 44.0% EWL). LAGB reduced HbA1c from 5.8% (2-13.8) to 5.6% (0.3-12.3). LRYGB reduced HbA1c from 5.9% (2.0-12.3) to 5.4% (0.1-9.8). LAGB reduced HOMA IR from 3.6 (0.8-39.2) to 2.3 (0-55) and LRYGB reduced HOMA IR from 4.4 (0.6-56.5) to 1.4 (0.3-15.2). Postoperative HOMA IR correlated best with %EWL. Indeed, regression equations were essentially identical for LAGB and LRYGB for drop in %EWL versus postoperative HOMA IR.
Percent excess weight loss significantly predicts postoperative insulin resistance (HOMA IR) during the first year following both LRYGB and LAGB.
减肥手术能显著改善糖代谢、降低胰岛素抵抗,并使许多患者的II型糖尿病得到临床缓解。然而,实现这些临床效果的机制仍不明确。此外,各种手术对胰岛素抵抗的相对影响仍存在激烈争议。因此,本研究的目的是直接比较腹腔镜Roux-en-Y胃旁路术(LRYGB)和腹腔镜可调节胃束带术(LAGB)对可比的病态肥胖患者组血红蛋白A1c(HbA1c)水平和胰岛素抵抗的影响。
数据前瞻性录入我们的减肥手术数据库并进行回顾性分析。患者选择手术方式。主要结局变量为超重减轻百分比(%EWL)、HbA1c和胰岛素抵抗稳态模型评估(HOMA IR)。
111例LAGB患者的随访次数为263次,中位随访时间为162天(17 - 1016天);104例LRYGB患者的随访次数为291次,中位随访时间为150天(8 - 1191天)。两组患者术前的身高、体重、体重指数、年龄、性别、种族、合并症、空腹血糖、胰岛素、HbA1c和HOMA IR相似。特别是,两组中糖尿病患者以及接受胰岛素和其他降糖药物治疗的患者数量相似。LAGB患者的体重减轻明显少于LRYGB患者(EWL分别为24.6%和44.0%)。LAGB使HbA1c从5.8%(2 - 13.8)降至5.6%(0.3 - 12.3)。LRYGB使HbA1c从5.9%(2.0 - 12.3)降至5.4%(0.1 - 9.8)。LAGB使HOMA IR从3.6(0.8 - 39.2)降至2.3(0 - 55),LRYGB使HOMA IR从4.4(0.6 - 56.5)降至1.4(0.3 - 15.2)。术后HOMA IR与%EWL的相关性最佳。实际上,LAGB和LRYGB在%EWL下降与术后HOMA IR方面的回归方程基本相同。
超重减轻百分比能显著预测LRYGB和LAGB术后第一年的胰岛素抵抗(HOMA IR)。